Delaware
|
001-31922
|
33-1022198
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
|
Item
2.02 Results from Operations and Financial
Condition
|
|
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change
in Fiscal Year
|
|
Item
7.01. Regulation FD
Disclosure
|
Exhibit
|
Description
|
3.1
|
|
99.1
|
Date: October 18,
2007
|
|||
Tempur-Pedic International Inc. | |||
|
By:
|
/s/ H. Thomas Bryant | |
Name: H. Thomas Bryant | |||
Title: President and Chief Executive Officer |
EXHIBIT
INDEX
|
Exhibit
|
Description
|
3.1
|
|
99.1
|
|
|
Page
|
||
|
|
|
||
Article I.
|
General
|
1
|
||
1.1.
|
Offices
|
1
|
||
1.2.
|
Seal
|
1
|
||
1.3.
|
Fiscal
Year
|
1
|
||
|
|
|||
Article
II.
|
Stockholders
|
1
|
||
2.1.
|
Place of Meetings |
1
|
||
2.2.
|
Annual Meeting |
1
|
||
2.3.
|
Quorum |
1
|
||
2.4.
|
Right to Vote; Proxies |
2
|
||
2.5.
|
Voting |
2
|
||
2.6.
|
Notice of Annual Meetings |
2
|
||
2.7.
|
Stockholders' List |
2
|
||
2.8.
|
Special Meetings |
2
|
||
2.9.
|
Notice of Special Meetings |
3
|
||
2.10.
|
Inspectors |
3
|
||
2.11.
|
Stockholders' Consent in Lieu of Meetings |
3
|
||
2.12.
|
Procedures |
3
|
||
|
|
|||
Article
III.
|
Directors
|
4
|
||
3.1.
|
Number of Directors |
4
|
||
3.2.
|
Resignation |
4
|
||
3.3.
|
Removal |
4
|
||
3.4.
|
Place of Meetings and Books |
4
|
||
3.5.
|
General Powers |
4
|
||
3.6.
|
Committees |
4
|
||
3.7.
|
Powers Denied to Committees |
5
|
||
3.8.
|
Substitute Committee Member |
5
|
||
3.9.
|
Compensation of Directors |
5
|
||
3.10.
|
Regular Meetings |
5
|
||
3.11.
|
Special Meetings |
5
|
||
3.12.
|
Quorum |
6
|
||
3.13.
|
Telephonic Participation in Meetings |
6
|
||
3.14.
|
Action by Consent |
6
|
||
|
|
|||
Article
IV.
|
Officers
|
6
|
||
4.1.
|
Selection; Statutory Officers |
6
|
||
4.2.
|
Time of Election |
6
|
||
4.3.
|
Additional Officers |
6
|
||
4.4.
|
Terms of Office |
6
|
||
4.5.
|
Compensation of Officers |
7
|
||
4.6.
|
Chairman of the Board |
7
|
||
4.7.
|
President
|
7
|
||
4.8.
|
Vice-Presidents |
7
|
||
4.9.
|
Treasurer |
7
|
||
4.10.
|
Secretary |
7
|
||
4.11.
|
Assistant Secretary |
8
|
||
4.12.
|
Assistant Treasurer |
8
|
||
4.13.
|
Subordinate Officers |
8
|
||
|
|
|||
Article
V.
|
Stock
|
8
|
||
5.1.
|
Stock |
8
|
||
5.2.
|
Fractional Share Interests |
9
|
||
5.3.
|
Transfers of Stock |
9
|
||
5.4.
|
Record Date |
9
|
||
5.5.
|
Transfer Agent and Registrar |
9
|
||
5.6.
|
Dividends |
10
|
||
5.7.
|
Lost, Stolen, or Destroyed Certificates |
10
|
||
5.8.
|
Inspection of Books |
10
|
||
|
|
|||
Article
VI.
|
Miscellaneous
Management Provisions
|
10
|
||
6.1.
|
Checks, Drafts, and Notes |
10
|
||
6.2.
|
Notices |
10
|
||
6.3.
|
Conflict of Interest |
11
|
||
6.4.
|
Voting of Securities Owned by the Company |
11
|
||
|
|
|||
Article
VII.
|
Indemnification
|
11
|
||
7.1.
|
Right of Indemnification |
11
|
||
7.2.
|
Right of Indemnitee to Bring Suit |
12
|
||
7.3.
|
Non-Exclusivity of Rights |
12
|
||
7.4.
|
Insurance |
12
|
||
7.5.
|
Indemnification of Employees and Agents of the Company |
12
|
||
|
|
|||
Article
VIII.
|
Amendments
|
12
|
||
8.1.
|
Amendments |
12
|
|
|
-
EPS
Up 44% in Third
Quarter
|
|
|
-
Net Sales Up 22% in Third
Quarter
|
|
|
-
Completed Prior $200 Million Share Repurchase
Authorization
|
|
|
-
Announces New $300 Million Share Repurchase
Authorization
|
|
|
-
Company Raises Financial Guidance for
2007
|
·
|
Earnings
per share increased 44% to $0.49 per diluted share in the third
quarter of
2007 as compared to $0.34 per diluted share in the third quarter
of
2006.
|
·
|
Net
sales rose 22% to $294.1 million in the third quarter of 2007 from
$240.9
million in the third quarter of 2006. Retail sales increased 27%
worldwide.
|
·
|
Operating
income increased 26% to $67.5 million in the third quarter of 2007
from
$53.7 million in the third quarter of 2006. The increase was principally
driven by incremental sales as well as modest operating expense
leverage.
|
·
|
Operating
cash flow increased to $55.7 million in the third quarter of 2007
from
$46.6 million in the third quarter of 2006. The increase was principally
driven by net income growth. In addition, capital expenditures
were $3.3
million in the third quarter of 2007, $2.3 million less than in
the third
quarter of 2006.
|
·
|
The
Company achieved net sales and unit growth across all products
and both
geographic segments. Worldwide mattress revenue increased 22%.
Worldwide
mattress unit growth was 17% led by domestic mattress unit growth
of 22%.
Pillow sales rose 15% worldwide driven by unit growth of 12%. Domestic
pillow units were especially strong, up
23%.
|
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||||||||||
September
30,
|
September
30,
|
|||||||||||||||||||||||
2007
|
2006
|
Chg
%
|
2007
|
2006
|
Chg
%
|
|||||||||||||||||||
Net
sales
|
$ |
294,094
|
$ |
240,917
|
22 | % | $ |
817,768
|
$ |
688,465
|
19 | % | ||||||||||||
Cost
of sales
|
152,484
|
124,894
|
423,930
|
354,672
|
||||||||||||||||||||
Gross
profit
|
141,610
|
116,023
|
22 | % |
393,838
|
333,793
|
18 | % | ||||||||||||||||
Selling
and marketing expenses
|
48,830
|
41,827
|
144,630
|
127,230
|
||||||||||||||||||||
General
and administrative expenses
|
23,628
|
19,235
|
68,497
|
55,521
|
||||||||||||||||||||
Research
and development expenses
|
1,603
|
1,240
|
4,278
|
3,031
|
||||||||||||||||||||
Operating
income
|
67,549
|
53,721
|
26 | % |
176,433
|
148,011
|
19 | % | ||||||||||||||||
Other
expense, net:
|
||||||||||||||||||||||||
Interest
expense, net
|
(8,261 | ) | (6,728 | ) | (21,394 | ) | (17,402 | ) | ||||||||||||||||
Loss
on extinguishment of debt
|
—
|
—
|
(126 | ) |
—
|
|||||||||||||||||||
Other
expense, net
|
(33 | ) | (183 | ) | (410 | ) | (142 | ) | ||||||||||||||||
Total
other expense
|
(8,294 | ) | (6,911 | ) | (21,930 | ) | (17,544 | ) | ||||||||||||||||
Income
before income taxes
|
59,255
|
46,810
|
27 | % |
154,503
|
130,467
|
18 | % | ||||||||||||||||
Income
tax provision
|
20,437
|
17,947
|
52,974
|
48,599
|
||||||||||||||||||||
Net
income
|
$ |
38,818
|
$ |
28,863
|
34 | % | $ |
101,529
|
$ |
81,868
|
24 | % | ||||||||||||
Earnings
per share:
|
||||||||||||||||||||||||
Basic
|
$ |
0.50
|
$ |
0.35
|
$ |
1.25
|
$ |
0.96
|
||||||||||||||||
Diluted
|
$ |
0.49
|
$ |
0.34
|
$ |
1.22
|
$ |
0.92
|
||||||||||||||||
Weighted
average shares outstanding:
|
||||||||||||||||||||||||
Basic
|
77,725
|
82,946
|
81,522
|
85,533
|
||||||||||||||||||||
Diluted
|
79,173
|
85,681
|
83,069
|
88,666
|
September
30,
|
December
31,
|
|||||||||||
2007
|
2006
|
Chg
%
|
||||||||||
ASSETS
|
||||||||||||
Current
Assets:
|
||||||||||||
Cash
and cash equivalents
|
$ |
23,580
|
$ |
15,788
|
||||||||
Accounts
receivable, net
|
165,735
|
142,059
|
||||||||||
Inventories
|
82,065
|
61,736
|
||||||||||
Prepaid
expenses and other current assets
|
13,053
|
8,002
|
||||||||||
Income
taxes receivable
|
—
|
588
|
||||||||||
Deferred
income taxes
|
9,566
|
9,383
|
||||||||||
Total
Current Assets
|
293,999
|
237,556
|
24 | % | ||||||||
Property,
plant and equipment, net
|
208,140
|
215,428
|
||||||||||
Goodwill
|
198,623
|
198,207
|
||||||||||
Other
intangible assets, net
|
69,014
|
70,826
|
||||||||||
Deferred
financing and other non-current assets, net
|
4,044
|
3,649
|
||||||||||
Total
Assets
|
$ |
773,820
|
$ |
725,666
|
7 | % | ||||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
||||||||||||
Current
Liabilities:
|
||||||||||||
Accounts
payable
|
$ |
64,880
|
$ |
51,220
|
||||||||
Accrued
expenses and other
|
74,364
|
61,050
|
||||||||||
Income
taxes payable
|
15,751
|
—
|
||||||||||
Current
portion of long-term debt
|
282
|
19,497
|
||||||||||
Total
Current Liabilities
|
155,277
|
131,767
|
18 | % | ||||||||
Long-term
debt
|
555,805
|
341,635
|
||||||||||
Deferred
income taxes
|
34,294
|
38,536
|
||||||||||
Other
non-current liabilities
|
330
|
380
|
||||||||||
Total
Liabilities
|
745,706
|
512,318
|
46 | % | ||||||||
Stockholders’
Equity:
|
||||||||||||
Common
stock, $.01 par value; 300,000 shares authorized;
99,215 shares issued as of September 30, 2007 and December 31,
2006
|
992
|
992
|
||||||||||
Additional
paid in capital
|
280,638
|
264,709
|
||||||||||
Retained
earnings
|
207,797
|
140,608
|
||||||||||
Accumulated
other comprehensive income
|
11,586
|
3,992
|
||||||||||
Treasury
stock, at cost; 24,110 and 15,993 shares as of September 30,
2007 and
December 31, 2006, respectively
|
(472,899 | ) | (196,953 | ) | ||||||||
Total
Stockholders’ Equity
|
28,114
|
213,348
|
(87 | )% | ||||||||
Total
Liabilities and Stockholders’ Equity
|
$ |
773,820
|
$ |
725,666
|
7 | % |
Nine
Months Ended
|
||||||||||||
September
30,
|
||||||||||||
2007
|
2006
|
Chg
%
|
||||||||||
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
||||||||||||
Net
income
|
$ |
101,529
|
$ |
81,868
|
||||||||
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
||||||||||||
Depreciation
and amortization
|
25,326
|
18,640
|
||||||||||
Amortization
of deferred financing costs
|
719
|
1,479
|
||||||||||
Loss
on extinguishment of debt
|
126
|
—
|
||||||||||
Amortization
of stock-based compensation
|
5,081
|
2,672
|
||||||||||
Provision
for doubtful accounts
|
4,541
|
2,813
|
||||||||||
Deferred
income taxes
|
(3,101 | ) | (2,479 | ) | ||||||||
Foreign
currency adjustments
|
661
|
243
|
||||||||||
Loss
on sale of equipment and other
|
101
|
207
|
||||||||||
Changes
in operating assets and liabilities:
|
||||||||||||
Accounts
receivable
|
(22,585 | ) | (23,696 | ) | ||||||||
Inventories
|
(14,228 | ) |
18,545
|
|||||||||
Prepaid
expenses and other current assets
|
(5,035 | ) |
725
|
|||||||||
Accounts
payable
|
10,250
|
5,351
|
||||||||||
Accrued
expenses and other
|
10,636
|
3,986
|
||||||||||
Income
taxes
|
25,864
|
28,926
|
||||||||||
Excess
tax benefit from stock based compensation
|
(10,025 | ) | (6,189 | ) | ||||||||
Net
cash provided by operating activities
|
129,860
|
133,091
|
(2 | %) | ||||||||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
||||||||||||
Payments
for trademarks and other intellectual property
|
(636 | ) | (699 | ) | ||||||||
Purchases
of property, plant and equipment
|
(8,181 | ) | (24,159 | ) | ||||||||
Acquisition
of businesses
|
(5,756 | ) |
—
|
|||||||||
Proceeds
from sale of equipment
|
135
|
83
|
||||||||||
Net
cash used by investing activities
|
(14,438 | ) | (24,775 | ) | 42 | % | ||||||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
||||||||||||
Proceeds
from long-term revolving credit facility
|
347,547
|
152,000
|
||||||||||
Repayments
of long-term revolving credit facility
|
(119,293 | ) | (55,000 | ) | ||||||||
Repayments
of long-term debt
|
(45,416 | ) | (70,622 | ) | ||||||||
Proceeds
from issuance of Series A Industrial Revenue Bonds
|
15,385
|
—
|
||||||||||
Repayment
of Series A Industrial Revenue Bonds
|
(5,765 | ) | (3,840 | ) | ||||||||
Proceeds
from exercise of stock options
|
8,078
|
3,401
|
||||||||||
Excess
tax benefit from stock based compensation
|
10,025
|
6,189
|
||||||||||
Treasury
stock repurchased
|
(299,998 | ) | (144,000 | ) | ||||||||
Dividend
paid to stockholders
|
(17,895 | ) |
—
|
|||||||||
Payments
for deferred financing costs
|
(1,530 | ) | (698 | ) | ||||||||
Net
cash used by financing activities
|
(108,862 | ) | (112,570 | ) | 2 | % | ||||||
NET
EFFECT OF EXCHANGE RATE CHANGES ON CASH
|
1,232
|
1,652
|
||||||||||
Increase/(Decrease)
in cash and cash equivalents
|
7,792
|
(2,602 | ) | |||||||||
CASH
AND CASH EQUIVALENTS, beginning of period
|
15,788
|
17,855
|
||||||||||
CASH
AND CASH EQUIVALENTS, end of period
|
$ |
23,580
|
$ |
15,253
|
55 | % |
($
in thousands)
|
||||||||||||||||||||||||
CONSOLIDATED
|
DOMESTIC
|
INTERNATIONAL
|
||||||||||||||||||||||
Three
Months Ended
|
Three
Months Ended
|
Three
Months Ended
|
||||||||||||||||||||||
September
30,
|
September
30,
|
September
30,
|
||||||||||||||||||||||
2007
|
2006
|
2007
|
2006
|
2007
|
2006
|
|||||||||||||||||||
By
Sales Channel
|
||||||||||||||||||||||||
Retail
|
$ |
251,452
|
$ |
198,659
|
$ |
177,372
|
$ |
139,883
|
$ |
74,080
|
$ |
58,776
|
||||||||||||
Direct
|
18,009
|
20,608
|
15,140
|
18,214
|
2,869
|
2,394
|
||||||||||||||||||
Healthcare
|
12,384
|
10,522
|
4,222
|
3,099
|
8,162
|
7,423
|
||||||||||||||||||
Third
Party
|
12,249
|
11,128
|
3,717
|
3,250
|
8,532
|
7,878
|
||||||||||||||||||
Total
|
$ |
294,094
|
$ |
240,917
|
$ |
200,451
|
$ |
164,446
|
$ |
93,643
|
$ |
76,471
|
($
in thousands)
|
||||||||||||||||||||||||
CONSOLIDATED
|
DOMESTIC
|
INTERNATIONAL
|
||||||||||||||||||||||
Three
Months Ended
|
Three
Months Ended
|
Three
Months Ended
|
||||||||||||||||||||||
September
30,
|
September
30,
|
September
30,
|
||||||||||||||||||||||
2007
|
2006
|
2007
|
2006
|
2007
|
2006
|
|||||||||||||||||||
Net
Sales
|
||||||||||||||||||||||||
Mattresses
|
$ |
207,341
|
$ |
169,334
|
$ |
149,221
|
$ |
122,117
|
$ |
58,120
|
$ |
47,217
|
||||||||||||
Pillows
|
34,418
|
29,934
|
17,960
|
14,863
|
16,458
|
15,071
|
||||||||||||||||||
Other
|
52,335
|
41,649
|
33,270
|
27,466
|
19,065
|
14,183
|
||||||||||||||||||
Total
|
$ |
294,094
|
$ |
240,917
|
$ |
200,451
|
$ |
164,446
|
$ |
93,643
|
$ |
76,471
|